Program
Meeting Archives

Schedule of Events

Presenter disclosures will available here once presenters have been invited/confirmed and their potential conflicts of interests have been reviewed and managed.

[M] = medical oncologist, [R] = radiation oncologist, [S] = surgeon/surgical oncologist

Wednesday, February 26, 2020

Thursday, February 27, 2020

Friday, February 28, 2020

Saturday, February 29, 2020

7:00 a.m. - 4:15 p.m.	Registration
7:00 a.m. - 8:00 a.m.	Continental Breakfast
7:55 a.m. - 8:00 a.m.	Day One Welcome
8:00 a.m. - 9:30 a.m.	Oral Cavity Guidelines for Oral Cavity Surgery for Oral Cavity Carcinoma Radiation Oncology for Oral Cavity Carcinoma Systemic Therapy for Oral Cavity Cancer Questions and Answers
9:30 a.m. - 10:15 a.m.	Keynote I: Cutting-edge Combinations with Radiation
10:15 a.m. - 10:45 a.m.	Coffee Break
10:45 a.m. - 12:15 p.m.	K. Kian Ang, MD, PhD, FASTRO, Commemorative Plenary Session
12:15 p.m. - 1:15 p.m.	Lunch Expert Office Hours
1:15 p.m. - 2:45 p.m.	HPV-associated Tonsil and Base of Tongue Squamous Cell Carcinoma Guidelines for Tonsil and Base of Tongue Challenges in Deintensification of Radiation Therapy New Staging and How It Affects (or Could Affect) Therapy Adjuvant Therapy in HPV-associated Head and Neck Cancer HPV: Where do we go next? Question and Answers
2:45 p.m. - 3:15 p.m.	Coffee Break
3:15 p.m. - 4:15 p.m.	Tumor Board: Early-stage Disease
4:15 p.m. - 5:15 p.m.	Poster Viewing Session and Reception

7:00 a.m. - 5:30 p.m.	Registration
7:00 a.m. - 8:00 a.m.	Continental Breakfast
7:55 a.m. - 8:00 a.m.	Day Two Welcome
8:00 a.m. - 9:30 a.m.	Larynx/Hypopharynx Guidelines for Larynx/Hypopharynx Surgical Approaches for Early Laryngeal Cancer Role of Induction Guidelines for Target Delineation Questions and Answers
9:30 a.m. - 10:15 a.m.	Keynote II: Immune-related Therapies and Clinical Trial Updates
10:15 a.m. - 10:45 a.m.	Coffee Break
10:45 a.m. - 12:15 p.m.	Oral Abstract Session
12:15 p.m. - 1:15 p.m.	Lunch Trainee and Early-career Networking Luncheon
1:15 p.m. - 2:45 p.m.	Rare Cancers of the Head and Neck Challenges in Salivary Gland and Sinonasal Neuroendocrine Pathology Salivary Gland Cancer Esthesioneuroblastoma Sinonasal Neuroendocrine and Undifferentiated Carcinomas
2:45 p.m. - 3:15 p.m.	Coffee Break
3:15 p.m. - 4:30 p.m.	Breakout Session I: Advances in Molecular Imaging Intraoperative Molecular Imaging FDG-PET Update in Head and Neck Cancer Predicting Immunotherapy in Head and Neck Cancer Questions and Answers Breakout Session II: Survivorship Financial Toxicity and Employment in Head and Neck Cancer Patients Vascular Disease in Head and Neck Cancer Survivorship Are Current PROs Adequate for Head and Neck Cancer Patients? Dental Evaluation in the Head and Neck Cancer Patient Questions and Answers
4:30 p.m. - 5:30 p.m.	Tumor Board: Advanced Disease

7:00 a.m. - 12:15 p.m.	Registration
7:00 a.m. - 8:00 a.m.	Continental Breakfast
7:55 a.m. - 8:00 a.m.	Welcome
8:00 a.m. - 9:30 a.m.	Advances in Immunotherapy Established and Emerging Biomarkers for Immunotherapy Combination Immunotherapy Role of Immunotherapy in Curative Intent Cellular Therapy Questions and Answers
9:30 a.m. - 10:15 a.m.	De-escalation Debate
10:15 a.m. - 10:45 a.m.	Coffee Break
10:45 a.m. - 12:15 p.m.	Cutaneous Squamous Cell Carcinoma and Carcinoma of Unknown Primary Guidelines for Unknown Primary Management Pathology for Unknown Primary and How to Grade Perineural Invasion for Skin Cancer Radiation Oncology for Skin Cancer Systemic Treatment of Skin Cancer Questions and Answers